[Featured Stock] Lunit, Participating in US 'CancerX', Surges Over 6%
The stock price of Lunit, a medical artificial intelligence (AI) company, is on the rise.
As of 2:34 PM on the 10th, Lunit is trading at 96,100 KRW, up 6.54% compared to the previous trading day.
![[Featured Stock] Lunit, Participating in US 'CancerX', Surges Over 6%](http://www.asiae.co.kr/news/img_view.htm?img=2023011708272485802_1673911645.jpeg)
On this day, Lunit announced that it will participate in the first project of 'CancerX,' a public-private partnership established for the US government's cancer conquest project 'Cancer Moonshot.' Lunit plans to contribute to the project by providing its AI image analysis solution product line, Lunit Insight.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Controversy Over Mysterious Numbers at Starbucks: From Sewol Ferry and Park Geun-hye to May 18
- Cost Instability Grips 'AI Rally'... Iran War Identified as the Cause
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
CancerX announced its founding members in June, including 92 companies such as global pharmaceutical firms Takeda Pharmaceutical, AstraZeneca, and Genentech, with Lunit being the only Korean company listed as a founding member.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
